
UPDATE 1-AbbVie profit beats expectations on Humira demand – Reuters
AbbVie Inc forecast annual profit above expectations and beat quarterly estimates on Wednesday on higher demand for its blockbuster drug Humira as well as newer treatments for psoriasis and rheumatoid arthritis, sending its shares up 1.7%.